AV
Ashitha Vilangott Nhalil
About Ashitha Vilangott Nhalil
Data last updated:
Ashitha Vilangott Nhalil is a Director at Glycemia Anti Diabetic Clinic Private Limited (since 2017) and Director at Glycemia Biotech Private Limited (since 2024). The companies operate in Healthcare and Paper. The largest current company by reported revenue is Glycemia Anti Diabetic Clinic Private Limited at ₹74 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2017 | 2017 | ₹74 Lakh (FY 2025) | Active | |
| Director | 25 Nov 2024 | 2024 | Active |
Board colleagues of Ashitha Vilangott Nhalil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aneesh Kalli | 07482535 | Glycemia Anti Diabetic Clinic Private Limited , Glycemia Biotech Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashitha Vilangott Nhalil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashitha Vilangott Nhalil
Ashitha Vilangott Nhalil currently holds 2 directorships: Glycemia Anti Diabetic Clinic Private Limited (Director, since 06 Feb 2017, revenue ₹74 Lakh (FY 2025)); Glycemia Biotech Private Limited (Director, since 25 Nov 2024).
Ashitha Vilangott Nhalil was first appointed on 06 Feb 2017 as Director at Glycemia Anti Diabetic Clinic Private Limited. The most recent appointment on record is 25 Nov 2024 at Glycemia Biotech Private Limited.
The current boards of Ashitha Vilangott Nhalil's companies include Aneesh Kalli (Glycemia Anti Diabetic Clinic Private Limited).